Literature DB >> 33356612

To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.

Emily A Erdmann1, Ananya Mahapatra1, Priyanka Mukherjee2, Boyoon Yang3, Heather A Hundley2.   

Abstract

Adenosine deaminases that act on RNA (ADARs) are present in all animals and function to both bind double-stranded RNA (dsRNA) and catalyze the deamination of adenosine (A) to inosine (I). As inosine is a biological mimic of guanosine, deamination by ADARs changes the genetic information in the RNA sequence and is commonly referred to as RNA editing. Millions of A-to-I editing events have been reported for metazoan transcriptomes, indicating that RNA editing is a widespread mechanism used to generate molecular and phenotypic diversity. Loss of ADARs results in lethality in mice and behavioral phenotypes in worm and fly model systems. Furthermore, alterations in RNA editing occur in over 35 human pathologies, including several neurological disorders, metabolic diseases, and cancers. In this review, a basic introduction to ADAR structure and target recognition will be provided before summarizing how ADARs affect the fate of cellular RNAs and how researchers are using this knowledge to engineer ADARs for personalized medicine. In addition, we will highlight the important roles of ADARs and RNA editing in innate immunity and cancer biology.

Entities:  

Keywords:  ADAR; Double-stranded RNA (dsRNA); RNA editing; RNA modification; cancer; dsRBP; innate immunity; inosine

Mesh:

Substances:

Year:  2020        PMID: 33356612      PMCID: PMC8019592          DOI: 10.1080/10409238.2020.1856768

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  240 in total

1.  Cardiac valve involvement in ADAR-related type I interferonopathy.

Authors:  Yanick Crow; Nandaki Keshavan; Jacques Patrick Barbet; Geanina Bercu; Vincent Bondet; Charlotte Boussard; Nathalie Dedieu; Darragh Duffy; Marie Hully; Alessandro Giardini; Cyril Gitiaux; Gillian Inara Rice; Luis Seabra; Brigitte Bader-Meunier; Shamima Rahman
Journal:  J Med Genet       Date:  2019-11-26       Impact factor: 6.318

Review 2.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

Review 3.  To edit or not to edit: regulation of ADAR editing specificity and efficiency.

Authors:  Sarah N Deffit; Heather A Hundley
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-11-26       Impact factor: 9.957

4.  Effects of ADARs on small RNA processing pathways in C. elegans.

Authors:  M Bryan Warf; Brent A Shepherd; W Evan Johnson; Brenda L Bass
Journal:  Genome Res       Date:  2012-06-06       Impact factor: 9.043

5.  Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis.

Authors:  Patrice Vitali; A D J Scadden
Journal:  Nat Struct Mol Biol       Date:  2010-08-08       Impact factor: 15.369

6.  hiCLIP reveals the in vivo atlas of mRNA secondary structures recognized by Staufen 1.

Authors:  Yoichiro Sugimoto; Alessandra Vigilante; Elodie Darbo; Alexandra Zirra; Cristina Militti; Andrea D'Ambrogio; Nicholas M Luscombe; Jernej Ule
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

7.  RNA editing in nascent RNA affects pre-mRNA splicing.

Authors:  Yun-Hua Esther Hsiao; Jae Hoon Bahn; Yun Yang; Xianzhi Lin; Stephen Tran; Ei-Wen Yang; Giovanni Quinones-Valdez; Xinshu Xiao
Journal:  Genome Res       Date:  2018-05-03       Impact factor: 9.043

8.  Inosine induces context-dependent recoding and translational stalling.

Authors:  Konstantin Licht; Markus Hartl; Fabian Amman; Dorothea Anrather; Michael P Janisiw; Michael F Jantsch
Journal:  Nucleic Acids Res       Date:  2019-01-10       Impact factor: 16.971

9.  Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.

Authors:  Alexander S Thuy-Boun; Justin M Thomas; Herra L Grajo; Cody M Palumbo; SeHee Park; Luan T Nguyen; Andrew J Fisher; Peter A Beal
Journal:  Nucleic Acids Res       Date:  2020-08-20       Impact factor: 16.971

10.  The octopus genome and the evolution of cephalopod neural and morphological novelties.

Authors:  Caroline B Albertin; Oleg Simakov; Therese Mitros; Z Yan Wang; Judit R Pungor; Eric Edsinger-Gonzales; Sydney Brenner; Clifton W Ragsdale; Daniel S Rokhsar
Journal:  Nature       Date:  2015-08-13       Impact factor: 49.962

View more
  6 in total

1.  Harnessing Nature's Molecular Recognition Capabilities to Map and Study RNA Modifications.

Authors:  Ansley S Felix; Alexandria L Quillin; Shikufa Mousavi; Jennifer M Heemstra
Journal:  Acc Chem Res       Date:  2022-07-28       Impact factor: 24.466

2.  ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide.

Authors:  Reshma Raghava Kurup; Eimile K Oakes; Pranathi Vadlamani; Obi Nwosu; Pranav Danthi; Heather A Hundley
Journal:  Sci Rep       Date:  2022-08-03       Impact factor: 4.996

Review 3.  ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations.

Authors:  Khadija Hajji; Jiří Sedmík; Anna Cherian; Damiano Amoruso; Liam P Keegan; Mary A O'Connell
Journal:  RNA       Date:  2022-07-21       Impact factor: 5.636

Review 4.  ADAR1-Mediated RNA Editing and Its Role in Cancer.

Authors:  Jizhe Liu; Fei Wang; Yindan Zhang; Jingfeng Liu; Bixing Zhao
Journal:  Front Cell Dev Biol       Date:  2022-07-11

5.  RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.

Authors:  Yi Li; Ning-Xi Wang; Chuan Yin; Shan-Shan Jiang; Jia-Chu Li; Sheng-Yong Yang
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

6.  RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.

Authors:  Yasuhiro Komatsu; Kunitoshi Shigeyasu; Shuya Yano; Sho Takeda; Kazutaka Takahashi; Nanako Hata; Hibiki Umeda; Kazuhiro Yoshida; Yoshiko Mori; Kazuya Yasui; Ryuichi Yoshida; Yoshitaka Kondo; Hiroyuki Kishimoto; Fuminori Teraishi; Yuzo Umeda; Shunsuke Kagawa; Hiroyuki Michiue; Hiroshi Tazawa; Ajay Goel; Toshiyoshi Fujiwara
Journal:  Sci Rep       Date:  2022-08-08       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.